Effect of bevacizumab plus XELOX (CapeOX) chemotherapy on liver natural killer cell activity in colorectal cancer with resectable liver metastasis

AIM: We investigated the chemotherapy effect of resectable colorectal cancer with liver metastasis (CRLM) on the function of intrahepatic immune cells. METHODS: We classified patients into adjuvant chemotherapy (bevacizumab+CapeOX) after hepatectomy group (group A) and neoadjuvant chemotherapy follo...

詳細記述

保存先:
書誌詳細
出版年:Ann Gastroenterol Surg
主要な著者: Hirata, Fumihiro, Ishiyama, Kohei, Tanaka, Yuka, Kobayashi, Tsuyoshi, Hashimoto, Masakazu, Saeki, Yoshihiro, Ishida, Nobuki, Taguchi, Kazuhiro, Tanaka, Junko, Arihiro, Koji, Ohdan, Hideki
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2018
主題:
Original Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6139723/
https://ncbi.nlm.nih.gov/pubmed/30238080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ags3.12195
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料